Consumer Health in France
Consumer health in 2024: The big picture
What next for consumer health?
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
Table 2 Life Expectancy at Birth 2019-2024
Table 3 Sales of Consumer Health by Category: Value 2019-2024
Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024
Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024
Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
Table 8 Distribution of Consumer Health by Format: % Value 2019-2024
Table 9 Distribution of Consumer Health by Format and Category: % Value 2024
Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Summary 1 Research Sources
Analgesics in France
Analgesics beset by challenges in 2024
Despite the popularity of acetaminophen, ibuprofen’s woes erode overall category potential
Doliprane’s popularity consolidates Sanofi’s leadership position, while consumers fret over dearth of medical professionals
Self-medication on the rise, but uncertainty around pseudoephedrine dampens expectations for overall category
Retailers and manufacturers look to avoid shortages
Sanofi to divest itself of consumer health arm
Table 12 Sales of Analgesics by Category: Value 2019-2024
Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024
Table 14 NBO Company Shares of Analgesics: % Value 2020-2024
Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024
Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
Sleep Aids in France
Sleep aids continues to reap benefits from consumer stress and anxiety
Gummies gain rapid ground
Sanofi’s Novanuit remains overall leader
Demand set to continue throughout forecast period, despite challenges ahead
Possible new competition from other consumer health options
Potential for expansion in sea magnesium, melatonin and CBD
Table 18 Sales of Sleep Aids: Value 2019-2024
Table 19 Sales of Sleep Aids: % Value Growth 2019-2024
Table 20 NBO Company Shares of Sleep Aids: % Value 2020-2024
Table 21 LBN Brand Shares of Sleep Aids: % Value 2021-2024
Table 22 Forecast Sales of Sleep Aids: Value 2024-2029
Table 23 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
Cough, Cold and Allergy (Hay Fever) Remedies in France
2024 sees modest sales performance
Combination products witness another year of double-digit decline amid pseudoephedrine controversy
Ricola benefits from French consumers’ sweet tooth
As flu seasons settle down the impact will be offset by rising demand for antihistamines/allergy remedies
More innovation necessary amid intensifying competition, while ageing population will help to sustain sales
Growing preference among local consumers for natural remedies
Table 24 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024
Table 25 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024
Table 26 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024
Table 27 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
Dermatologicals in France
Dermatologicals deemed less important than other OTC offerings during times of financial uncertainty
Growth driven by return to pre-pandemic patterns
Stress and anxiety boost performance of hair loss treatments
Demographic and climate issues set to impact forecast performance
Continuous challenge from unclear positioning for dermatologicals
Under-exploited potential for vaginal antifungals, while medicated shampoos will maintain stable sales
Table 30 Sales of Dermatologicals by Category: Value 2019-2024
Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024
Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024
Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024
Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
Digestive Remedies in France
Robust growth results from consumer stress and sharp price hikes
Tourism boost helps motion sickness remedies, while Johnson & Johnson leads by a slight margin
Focus on gut health and demand for probiotics present challenge to growth
Stress and ageing to maintain future category growth
PPIs faces concerns over possible product misuse
Natural alternatives pose threat to OTC remedies
Table 37 Sales of Digestive Remedies by Category: Value 2019-2024
Table 38 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
Table 39 NBO Company Shares of Digestive Remedies: % Value 2020-2024
Table 40 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
Table 41 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
Table 42 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
Eye Care in France
Increase in pollen and airborne allergens boost category performance
Modern lifestyles also aid performance
Competitive landscape remains stable
Rising prevalence of myopia in France
Demand for eye care to forge ahead over the forecast period
OTC eye care evolves amid ophthalmologist shortages
Table 43 Sales of Eye Care by Category: Value 2019-2024
Table 44 Sales of Eye Care by Category: % Value Growth 2019-2024
Table 45 NBO Company Shares of Eye Care: % Value 2020-2024
Table 46 LBN Brand Shares of Eye Care: % Value 2021-2024
Table 47 Forecast Sales of Eye Care by Category: Value 2024-2029
Table 48 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
NRT Smoking Cessation Aids in France
Reimbursement remains key for category, limiting OTC penetration
Oral formats dominate, while players focus on mobile apps
Leading players take divergent approaches to boosting sales
Category will struggle over the forecast period
E-vapour products remain a serious competitive threat
Natural products unlikely to make any headway in NRT smoking cessation aids
Table 49 Number of Smokers by Gender 2019-2024
Table 50 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024
Table 51 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024
Table 52 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024
Table 53 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024
Table 54 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029
Table 55 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
Wound Care in France
Poor performance for wound care in 2024
URGO maintains leadership of overall wound care
Ongoing threat to pharmacies from grocery retail
Maturity contributes to forecast disappointing performance
Pure online and private label players hold further growth potential
Limited room for growth in products with value-added features
Table 56 Sales of Wound Care by Category: Value 2019-2024
Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024
Table 58 NBO Company Shares of Wound Care: % Value 2020-2024
Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024
Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
Sports Nutrition in France
Growth driven rising numbers of athletes interested in endurance sports and fitness
Explosion of gyms versus running and home-based training
Mainstream players face a new generation of competitors
Plenty of room for growth in a still-evolving market
Players to focus on finding new target audiences
Anticipated influx of new products and formats
Table 62 Sales of Sports Nutrition by Category: Value 2019-2024
Table 63 Sales of Sports Nutrition by Category: % Value Growth 2019-2024
Table 64 NBO Company Shares of Sports Nutrition: % Value 2020-2024
Table 65 LBN Brand Shares of Sports Nutrition: % Value 2021-2024
Table 66 Forecast Sales of Sports Nutrition by Category: Value 2024-2029
Table 67 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
Dietary Supplements in France
Another strong year of growth as consumers continue to opt for natural fixes
Category-wide dynamism is thanks to the promise of functional ingredients
Dermapharm leads while BMS enters the category with innovative offering
Favourable outlook thanks to increased focus on more natural products
Social media activity expected to drive growth
Pharmacies likely to reinforce leadership, as players focus more on benefits of eye health products
Table 68 Sales of Dietary Supplements by Category: Value 2019-2024
Table 69 Sales of Dietary Supplements by Category: % Value Growth 2019-2024
Table 70 Sales of Dietary Supplements by Positioning: % Value 2019-2024
Table 71 NBO Company Shares of Dietary Supplements: % Value 2020-2024
Table 72 LBN Brand Shares of Dietary Supplements: % Value 2021-2024
Table 73 Forecast Sales of Dietary Supplements by Category: Value 2024-2029
Table 74 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
Vitamins in France
Return to pre-pandemic trends for vitamins in France
Multivitamins too expensive for many, as vitamin D recovers from previous year’s dip
Growth set to continue during forecast period, benefitting from dietary trends
Multivitamin growth to stay stable
Vitamin D recommendation expected to accelerate growth
Table 75 Sales of Vitamins by Category: Value 2019-2024
Table 76 Sales of Vitamins by Category: % Value Growth 2019-2024
Table 77 Sales of Multivitamins by Positioning: % Value 2019-2024
Table 78 NBO Company Shares of Vitamins: % Value 2020-2024
Table 79 LBN Brand Shares of Vitamins: % Value 2021-2024
Table 80 Forecast Sales of Vitamins by Category: Value 2024-2029
Table 81 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
Weight Management and Wellbeing in France
Weight management and wellbeing continues to suffer in 2024
Evolving demand undermines interest in traditional category products
Detox, drainage and gummies
Category faces difficult road ahead
Customised coaching and new approaches
Ongoing development for supplement nutrition and slimming teas
Table 82 Sales of Weight Management and Wellbeing by Category: Value 2019-2024
Table 83 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024
Table 84 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024
Table 85 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024
Table 86 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029
Table 87 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
Herbal/Traditional Products in France
French consumers continue to shift towards herbal/traditional products
Sleep issues and stress support sales, as natural trends gain traction
Dermapharm as leading GBO through acquisition of Laboratoires Arkopharma, and demand for CBD-based variants rises rapidly
Ongoing favourable outlook for herbal/traditional products
NRT smoking cessation aids unlikely to be impacted by herbal and natural trends
Rising digestive complaints will support further category growth
Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
Paediatric Consumer Health in France
Ambivalent performance from paediatric consumer health in 2024
Non-chemical lice treatments gain momentum
Naturalness trend spreads throughout overall category
Changing demographics present challenges to growth
Rising demand for paediatric vitamins and dietary supplements with natural positioning
Paediatric consumer health to be further affected by shortages
Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029